Showing results (191-200 of 22,075) with videos related to
Sort By:
Pageof 2,208
Oncogene|October 12, 2010
Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesisK L Decicco-Skinner, E L Trovato, J K Simmons, et al.Oncogene|October 12, 2010
Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expressionJ Ahn, M Ko, C Lee, et al.Oncogene|March 1, 1990
Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycleS M Anderson, P M Carroll, F D LeeOncogene|March 1, 1990
Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogeneW L Hsiao, H L Pai, M S Matsui, et al.Oncogene|November 3, 2010
P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancerJ C Montero, S Seoane, A Ocaña, et al.Oncogene|November 3, 2010
Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancerB A Patrick, X Gong, A K JaiswalOncogene|September 15, 2010
eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancerS-H Goh, S-H Hong, S-H Hong, et al.Oncogene|September 15, 2010
Serine/threonine phosphatases in the DNA damage response and cancerA Peng, J L MallerOncogene|September 15, 2010
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1J Kalra, B W Sutherland, A L Stratford, et al.Oncogene|June 1, 1990
Dephosphorylation and activation of the T cell tyrosine kinase pp56lck by the leukocyte common antigen (CD45)T Mustelin, A AltmanPageof 2,208